Furthering the field of protein drug-conjugates
Portugal’s Institute of Molecular Medicine (IMM) will receive a scientific boost in its work on human genome research and developing new therapeutic approaches. The EU-funded SIMICA project will integrate the IMM into the European circle of research excellence institutions via a sustainable science, technology and innovation network comprising internationally-leading organisations in the field of protein drug-conjugates. SIMICA’s strategy is based on science- and innovation-driven clustering. It will focus on designing and constructing the next generation of chemically-defined and innovative protein drug-conjugates for the targeted treatment of serious conditions such as cancer. It will also offer training and mentoring opportunities for IMM’s young researchers.
Field of science
- /social sciences/economics and business/economics/sustainable economy
Call for proposal
See other projects for this call
Funding SchemeCSA - Coordination and support action